Labshake search
Citations for Bio X Cell :
1 - 50 of 144 citations for 7 CHLORO 4 HYDROXY 8 METHYLQUINOLINE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2021Quote: Intraperitoneal injections of αPDL1 (200 μg/injection on days 4, 8, 14, and 18; clone 10F.9G2; BioXcell), and HMGN1 and its-derived peptdies (0.08 μg on days 9 ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-IL-7 (BioXCell, 10 µg/ml), rmIL-7 or respective combinations ...
-
bioRxiv - Immunology 2022Quote: ... and anti-CD8 (clone 53.6-7, BioXcell) antibodies intraperitoneally twice per week ...
-
bioRxiv - Immunology 2022Quote: ... mice were rechallenged with 5×105 B16F10 GFP-LUC cells on day 75 post T cell transfer with or without intraperitoneal injection of 250 μg anti-Thy1.1 antibody (Days −7, 0, 7, 14, 21, 28, 35) (BioXCell) to deplete adoptively transferred pmel-1 T cells that are Thy1.1 expressing ...
-
bioRxiv - Cancer Biology 2022Quote: ... transduced cells were split and cultured with either recombinant murine (rm)IL-7 or 10 µg/ml neutralizing anti-IL-7 antibody (BE0048, Bio X Cell). Same protocol applied for STAT5ca-RV transduction ...
-
bioRxiv - Immunology 2020Quote: ... and/or human CD8α (Bioxcell, OKT-8) three days prior to first treatment and concurrently with subsequent treatments.
-
bioRxiv - Cell Biology 2020Quote: ... 8 and 11 anti-CTLA4 antibody (9H10; BioXCell) was administered interperitoneally at 200 μg per mouse ...
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-2 (8 μg/mL, Bio X Cell), anti–mIL-4 (8 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... anti–mIL-2 (8 μg/mL, Bio X Cell), anti–mIL-4 (8 μg/mL ...
-
bioRxiv - Immunology 2023Quote: ... or control IgG (n=8) (Syrian hamster IgG BioXCell), following the protocol depicted in Fig 4A.
-
bioRxiv - Immunology 2022Quote: ... and anti–mIFN-γ (8 μg/mL, Bio X Cell) (TH17 differentiation) ...
-
bioRxiv - Immunology 2021Quote: ... and anti–mIFN-γ (8 μg/mL, Bio X Cell) for TH17 differentiation ...
-
bioRxiv - Immunology 2023Quote: ... with the monoclonal antibody against human CD8 (clone OKT-8; BioXCell). The initial injection was 75 µg ...
-
bioRxiv - Immunology 2023Quote: ... and 8 post-infection with 200 ug of αCD8 (Clone 2.43 BioXcell) or control IgG antibody in 200 uL PBS (PMID ...
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Cancer Biology 2020Quote: ... intraperitoneal anti-CD-8 (Bio X Cell® BE0004-1 Clone 53-6.72) or control antibody was injected at a dose of 10 mg/kg on days 0 ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Immunology 2023Quote: ... mice were administered anti-p19 (clone G23-8) or istotype (rIgG1, clone HRPM; both BioXcell), 1 mg on d-1 and d+6 (47).
-
bioRxiv - Immunology 2024Quote: ... and IL-4-reactive monoclonal antibodies for in vivo studies (IL-4 MAb) were purchased from BioXCell (BE0045). All TLR agonists were purchased from Invivogen ...
-
bioRxiv - Immunology 2019Quote: ... anti-IL-4 (BioXcell, 11B11, 10ug/mL), IL-12 (Peprotech ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-4-1BB (clone LOB12.3, BioXCell) treatment ...
-
bioRxiv - Immunology 2022Quote: ... and 3μg/mL anti–IL-4 (BioXcell) were used ...
-
bioRxiv - Immunology 2023Quote: Studies of anti-CTLA-4 (BE0032, BioXcell) therapy in mice bearing CT26 and B16 tumors ...
-
bioRxiv - Immunology 2022Quote: ... were stimulated in 24-well plates pre-coated with 8 μg/ml anti-CD3 (17A2; BioXcell) and anti-CD28 (37.51 ...
-
bioRxiv - Immunology 2022Quote: ... Inhibition of CTLA-4 signaling was performed by intraperitoneal injection of 500μg/dose of αCTLA-4 (clone: UC10-4F10-11, BioXcell) supplemented with 1mg/dose of IgG2b isotype (clone ...
-
bioRxiv - Immunology 2021Quote: ... InVivoMAb anti-mouse/human integrin β7 (clone FIB504, BE0062) and InVivoMAb rat IgG2a isotype control, anti-trinitrophenol (clone 2A3, BE0089) antibodies were purchased from BioXCell.
-
bioRxiv - Neuroscience 2024Quote: ... MMTV-PyMT +/- female mice at 7 weeks after the tumor onset were intravenously injected with the anti-PD-L1 antibody (BioXcell, #BE0101 ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (10 µg/ml, BioXCell). Th1 cells were then cultured ...
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone: UC10-4F10-11, BioXcell) or isotype control antibodies (clone ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 Ab (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Cancer Biology 2020Quote: ... tumor-bearing mice were intraperitoneally injected (8-10mg/kg) with either an IgG2a isotype control antibody (BioXCell #BE0089), or an anti-PD-1 antibody (BioXCell #BE0146 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 200 µg of anti-CTLA-4 (BioXCell BE0164), or 400 µg of anti-IgG2b isotype control (BioXCell BE0090) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 200 μg anti-CTLA-4 (clone 9H10, BioXcell), or their respective IgG controls ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-IL-6 or anti-CTLA-4 antibodies (BioXCell). For CXCR3 blockade studies ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (clone 11B11, Bio X Cell). Briefly ...
-
bioRxiv - Immunology 2022Quote: ... 15 and αCTLA-4 (9H10; BioXcell; 200 μg/dose) on days 0 ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-4-1BB (clone LOB12.3, Bio X Cell #BP0169), anti-PD-1 (clone 29F.1A12 ...
-
bioRxiv - Immunology 2021Quote: ... and CTLA-4 blocking antibody (clone 9D9, BioXCell, cat. BE0164) were administered either in combination or as single agents at 100ug/antibody/mouse every third day starting on the day of doxycycline diet addition for four total doses.
-
bioRxiv - Microbiology 2020Quote: ... and 25 μg of anti-IL-4 (BioXcell, clone 11B11) were complexed prior to intraperitoneally injection into mice ...
-
bioRxiv - Cancer Biology 2019Quote: ... mice were randomized and treated with αCTLA-4 (BioXCell, BP0164) or isotype control (BioXcell ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Immunology 2021Quote: ... TREG conditions: anti–IL-4 (10 μg/mL, BioXCell, #BE0045), anti-IFN-γ (10 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... and 10 μg/mL a-IL-4 (clone 11B11, BioXCell). For Th17 conditions ...
-
bioRxiv - Immunology 2023Quote: ... Tumor-bearing mice were treated with anti-CTLA-4 (BioXCell) (n=8 ...